|
| |
CD38
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18322442 |
Regardless of CD38 expression level, CD38 and ZAP-70 expressions were significantly associated in B-CLL |
| 18178673 |
These results indicate a critical role for CD38 in TNFalpha-induced enhancement of [Ca(2+)](i) in human airway smooth muscle cells. |
| 12242463 |
Observational study of gene-disease association. (HuGE Navigator) |
| 15219386 |
Observational study of gene-disease association. (HuGE Navigator) |
| 16369895 |
Observational study of gene-disease association. (HuGE Navigator) |
| 16909600 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18162778 |
staining for TCL1, CD38, and CD44 are useful ancillary tests to identify B-cell tumors |
| 17931624 |
Results suggest that Zap-70 expression may be a better indicator of the mutational status of IgVH and prognosis of chronic lymphocytic leukemia than CD38 expression. |
| 18024373 |
CD38 and ZAP-70 are expressed in lymph node leukemic cells in both good and poor prognosis patients |
| 17684154 |
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. | →View more information from publications. |
Recent Publications on CD38: |  |
Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
Background aims The application of cord blood (CB)-derived hematopoietic... | 3rd November, 2009
| Stem Cell Biology Laboratory, National Institute of Immunology, Aruna Asaf
| Cytotherapy. 2009;11(6):768-77.
|
Immune changes in post-menopausal osteoporosis: the Immunos study.
The phenotypic and functional characteristics of immune cells of... | 31st October, 2009
| Service de Rhumatologie, CHU de Nice, Hopital l'Archet, Route Saint
| Osteoporos Int. 2009 Oct 30.
DOI Direct Link |
CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
INTRODUCTION: Aberrant signaling within and between B and T cells,... | 30th October, 2009
| Recherche et developpement, Hema-Quebec, Ingenierie cellulaire, 1070,
| Arch Immunol Ther Exp (Warsz). 2009 Oct 29.
DOI Direct Link |
[The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells]
OBJECTIVE: To investigate the drug resistance, proportion of leukemia stem... | 30th October, 2009
| Laboratory Center for Medical Science, School of Medicine, Lanzhou
| Zhonghua Yi Xue Za Zhi. 2009 Jul 7;89(25):1741-4.
|
Maxillofacial mass as the first presentation of acute lymphoblastic leukemia in a nine-year-old girl.
A nine-year-old girl complained of a maxillofacial mass and mild fever... | 27th October, 2009
| Department of Otolaryngology, 2nd Affiliated Hospital of Chinese PLA
| Auris Nasus Larynx. 2009 Oct 23.
DOI Direct Link |
→View more research publications. |
Press Releases on CD38:
|
 |
| Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH |
10th November, 2008 |
|
COPENHAGEN, November 10 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today that three ofatumumab
(HuMax-CD20(R)) abstracts have been accepted for presentation at the 50th
American Society of
|
| Genmab Reaches Milestone in Ofatumumab Collaboration |
10th October, 2008 |
|
COPENHAGEN, Denmark, October 10 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone
for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with
|
| Genmab Announces 2008 First Half Year Results |
27th August, 2008 |
|
COPENHAGEN, August 27 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the six month period
ended June 30, 2008. During this period, Genmab reported the following
results:
|
| Genmab Announces Upcoming Ofatumumab Studies |
25th August, 2008 |
|
COPENHAGEN, Denmark, August 25 /PRNewswire/ -- Genmab has announced plans to begin four studies of ofatumumab in chronic
lymphocytic leukemia and non-Hodgkin's lymphoma.
Genmab A
|
| Genmab Reaches Fifth Milestone in Ofatumumab Collaboration |
21st August, 2008 |
|
COPENHAGEN, August 21 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached the fifth milestone
for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with
|
CD38 results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for CD38,
or search for CD38 on BioPortfolio's antibody search engine.
This page has been viewed 324 times
Recent Search Terms used to find this page: NIMR5 antibody | HuMAX-CD38 | CD38 PE-Cy7 | human CD38 expression | cd38 cll 2009 | CD38 receptor synonyms | CD38 receptor synonyms | CD38 receptor synonyms | humax cd38 | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
